V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240010826 | 240007092 | 1.49 | 67.5 | Palliative (P) | 2019-02-16 | 2019-03-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240026516 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010827 | 240011832 | 1.71 | 77.8 | Curative (C) | 2015-04-27 | 2015-05-17 | Cisplatin + Radiotherapy | 2 | N | 240026528 | CISPLATIN + RT |
| 240010828 | 240007093 | null | 69.4 | Palliative (P) | 2013-08-26 | 2013-09-17 | Carboplatin + Paclitaxel (3 weekly) | null | N | 240026533 | CARBOPLATIN + PACLITAXEL |
| 240010829 | 240007094 | 1.56 | 60.1 | Curative (C) | 2018-07-11 | 2018-08-10 | Cisplatin + Radiotherapy | 2 | Y | 240026535 | CISPLATIN + RT |
| 240010830 | 240007096 | 1.65 | 41.6 | Curative (C) | 2014-12-17 | 2015-05-15 | Cisplatin + Radiotherapy | 02 | Y | 240026536 | CISPLATIN + RT |
| 240010831 | 240011834 | 1.76 | 58.9 | Palliative (P) | 2018-11-28 | 2018-11-28 | CARBOPLATIN + PACLITAXEL | N | N | 240026540 | CARBOPLATIN + PACLITAXEL |
| 240010832 | 240007098 | 1.62 | 62 | Disease modification (D) | 2015-06-30 | 2015-10-26 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240026543 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010833 | 240007099 | null | 76.2 | null | 2016-05-01 | 2016-05-01 | CARBOPLATIN + PACLITAXEL | 02 | N | 240026544 | CARBOPLATIN + PACLITAXEL |
| 240010834 | 240007101 | 1.57 | null | Curative (C) | 2017-07-23 | 2017-07-25 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 240026548 | CISPLATIN + RT |
| 240010835 | 240007101 | 1.84 | 62.8 | Adjuvant (A) | 2018-07-06 | 2018-07-12 | Cisplatin + Radiotherapy | 02 | N | 240026548 | CISPLATIN + RT |
| 240010836 | 240007101 | 1.59 | 68.5 | Palliative (P) | 2017-10-06 | 2017-10-13 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240026548 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010837 | 240007102 | null | 49.7 | Curative (C) | 2017-09-21 | 2017-11-29 | R GCVP | N | N | 240026583 | CVP R |
| 240010838 | 240007103 | 1.65 | 87.2 | Palliative (P) | 2018-04-30 | 2018-05-19 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 240026583 | CARBOPLATIN + PACLITAXEL |
| 240010839 | 240007103 | 1.59 | 53 | Palliative (P) | 2013-11-20 | 2013-12-10 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240026583 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010840 | 240007104 | 1.77 | 82 | Curative (C) | 2015-07-02 | 2015-07-06 | CVP R | 02 | N | 240026590 | CVP R |
| 240010841 | 240007105 | 1.6 | 81 | Curative (C) | 2015-08-03 | 2015-08-28 | CISPLATIN + RT | N | N | 240026594 | CISPLATIN + RT |
| 240010842 | 240011837 | 1.54 | null | Curative (C) | 2014-04-20 | 2014-05-19 | Cisplatin + Radiotherapy | N | Y | 240026599 | CISPLATIN + RT |
| 240010846 | 240007106 | 1.84 | 56.5 | Disease modification (D) | 2018-04-17 | 2018-08-02 | R GCVP | 02 | N | 240026620 | CVP R |
| 240010847 | 240007107 | 1.59 | 73.3 | Adjuvant (A) | null | 2014-12-08 | Carboplatin + Paclitaxel (3 weekly) | null | N | 240026622 | CARBOPLATIN + PACLITAXEL |
| 240010848 | 240007112 | 1.66 | 110.7 | Palliative (P) | 2016-05-19 | 2016-06-22 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240026624 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010849 | 240007113 | 1.56 | 65.5 | Curative (C) | 2015-01-14 | 2015-01-16 | CVP R | null | N | 240026626 | CVP R |
| 240010850 | 240007114 | 1.75 | null | Curative (C) | 2016-10-20 | 2017-02-15 | CVP R | 02 | null | 240026631 | CVP R |
| 240010851 | 240007114 | 1.52 | null | Palliative (P) | 2016-10-18 | 2016-11-22 | CARBOPLATIN + PACLITAXEL | N | N | 240026631 | CARBOPLATIN + PACLITAXEL |
| 240010852 | 240007114 | 1.74 | 87.4 | Disease modification (D) | 2018-11-07 | 2018-11-07 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | Y | 240026631 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010853 | 240007115 | 1.56 | 85 | Palliative (P) | 2018-02-02 | 2018-03-04 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240026645 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010854 | 240007116 | 1.57 | 107.9 | Palliative (P) | 2015-04-18 | 2015-04-28 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240026655 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010855 | 240007117 | 1.8 | 96 | Curative (C) | 2014-10-30 | 2014-11-03 | CISPLATIN + RT | 02 | null | 240026668 | CISPLATIN + RT |
| 240010856 | 240011840 | null | 58.4 | Curative (C) | 2017-05-21 | 2017-06-09 | CVP R | N | N | 240026669 | CVP R |
| 240010857 | 240011840 | 1.65 | 74 | Palliative (P) | 2018-08-03 | 2018-08-26 | CARBOPLATIN + PACLITAXEL | 02 | N | 240026669 | CARBOPLATIN + PACLITAXEL |
| 240010858 | 240007118 | 1.63 | 70 | Palliative (P) | 2016-04-29 | 2016-05-10 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240026682 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010859 | 240007118 | 1.73 | 48 | Curative (C) | 2015-05-12 | 2015-07-09 | CVP R | 02 | null | 240026682 | CVP R |
| 240010860 | 240014074 | 1.6 | 53 | Adjuvant (A) | 2015-12-31 | 2016-01-22 | CISPLATIN + RT | N | N | 240026714 | CISPLATIN + RT |
| 240010861 | 240007119 | 1.85 | 75.9 | Disease modification (D) | 2018-07-25 | 2018-08-09 | Cisplatin + Radiotherapy | 02 | null | 240026724 | CISPLATIN + RT |
| 240010862 | 240007120 | 1.72 | 79.1 | Palliative (P) | 2016-12-01 | 2016-12-01 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240026730 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010863 | 240011843 | 1.53 | 55.6 | Adjuvant (A) | 2016-08-18 | 2016-08-31 | CARBOPLATIN + PACLITAXEL | 02 | N | 240026734 | CARBOPLATIN + PACLITAXEL |
| 240010864 | 240007122 | 1.67 | 50.5 | Curative (C) | 2015-07-31 | 2015-07-31 | Cisplatin + Radiotherapy | 02 | Y | 240026737 | CISPLATIN + RT |
| 240010865 | 240007122 | null | 74 | Adjuvant (A) | 2018-07-27 | 2018-08-13 | CVP R | N | N | 240026737 | CVP R |
| 240010866 | 240007122 | 1.9 | 46 | Curative (C) | 2015-02-02 | 2015-02-18 | CVP R | N | N | 240026737 | CVP R |
| 240010867 | 240016075 | 1.7 | 82 | Palliative (P) | 2017-02-12 | 2017-02-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240026751 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010868 | 240016075 | 1.68 | null | Palliative (P) | 2018-09-16 | 2018-09-17 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240026751 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010869 | 240007123 | null | 36.85 | Curative (C) | 2015-09-02 | 2015-09-02 | Cisplatin + Radiotherapy | 02 | null | 240026762 | CISPLATIN + RT |
| 240010870 | 240007124 | 1.78 | 77.8 | Neo-adjuvant (N) | 2014-12-18 | 2015-01-06 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240026767 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010871 | 240011845 | 1.64 | null | null | 2014-09-05 | 2014-10-17 | CARBOPLATIN + PACLITAXEL | N | N | 240026767 | CARBOPLATIN + PACLITAXEL |
| 240010872 | 240011845 | null | 61 | Curative (C) | 2014-06-06 | 2014-06-16 | CVP R | N | N | 240026767 | CVP R |
| 240010873 | 240007126 | 1.6 | 80 | Palliative (P) | 2014-01-14 | 2014-06-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240026773 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240010874 | 240014078 | 1.55 | 62.8 | Curative (C) | 2018-02-03 | 2018-02-08 | CVP R | 2 | N | 240026791 | CVP R |
| 240010875 | 240007127 | 1.51 | 52 | Palliative (P) | 2013-10-31 | 2013-11-02 | Carboplatin + Paclitaxel (weekly) | 02 | N | 240026793 | CARBOPLATIN + PACLITAXEL |
| 240010876 | 240007128 | 1.73 | 74.5 | Palliative (P) | 2015-01-25 | 2015-02-05 | CVP R | 02 | N | 240026797 | CVP R |
| 240010877 | 240007129 | 1.56 | 81.9 | Not known (9) | 2017-06-11 | 2017-06-15 | CARBOPLATIN + PACLITAXEL | N | N | 240026797 | CARBOPLATIN + PACLITAXEL |
| 240010878 | 240014079 | 1.7 | 53 | Curative (C) | 2014-05-20 | 2014-05-25 | CARBOPLATIN + PACLITAXEL | N | N | 240026798 | CARBOPLATIN + PACLITAXEL |